I resolve to be optimistic about the latest CxBladder product launch.
Best Wishes
Paper Tiger
Printable View
I resolve to be optimistic about the latest CxBladder product launch.
Best Wishes
Paper Tiger
It was more of a personal thought from someone I know who invests in the share (like me) so I would be incorrect using the terminology "some quarters". I'm sorry about that. Though I don't doubt this is the thought of other investors or people who keenly follow PEB, because of the slower pace that the company has been ticking off its revenue goals, and signing up big commercial groups. I would have to agree with the person who shared this thought with me, so that's at least two people who agree with the notion.
A CEO or leadership group that negotiates more effectively with the transformational customers that have been identified could be the injection that the company needs to get out of 1st gear and into 3rd. A 'If-it-outperforms-what-you-have,-agree-to-pay-X-amount-of-the-tests' approach is critical at this point.
I'd like to qualify myself as a personal holder of PEB that wants them to succeed, and believes they will succeed, but thinks there should be a more aggressive (but still ethical) approach to negotiating sales deals with large clients, if the company is to hit near their $100m per year target.
Peoples lives are at stake.
Clinical validation is therefore required.
Pacific Edge obviously didnt have enough and it has taken time to get this.
With the current batch of launchings, publications in journals and results of clinical trials I think we may well be getting close.
The latest news indicates that trials were carried out in the US which would certainly help in any validation.
All the negotiating skills in the world wont do diddly squat unless you have clinical validation, peer reviewed and published.
So are you saying Skid that even though the US Medical system is in limbo at the moment if we change the marketing and deal making team or indeed the whole Pacific Edge Board we would see a sudden change in the growth of this company.
Im saying maybe Minors example is not enough,we shall see---The US medical system is in a state of uncertainty,and it appears cuts will be made--That may delay positive outcomes--And of course,if they had a marketing team that was able to negotiate a substantial deal,it would change the companies growth--finding a high profile company to partner with would also help IMO---My main point is that those deals dont make themselves,regardless of clinical validation(but of course it is better than not having it)--It could be good ammunition for a savvy negotiator.
Thats the ammunition I refered to--''but those deals dont make themselves,regardless of clinical validation--BUT OFCOURSE ITS BETTER THAN NOT HAVING IT ie-ammunition.
the difference in our opinion is that ,(from where Im sitting)you think clinical validation will be enough to achieve sales
and I think it will still take savvy negotiations-
Surely, if cuts are to be made as you suggest - then clinicians and administrators will be looking for lower cost solutions to providing health care for patients. PEB would seem to fit that bill perfectly and has the added advantages of being more convenient and non-invasive. Not sure that a lot of negotiating skill is required to present those messages - but as Miner says clinical validation is essential.
This has been discussed before---what you say makes sense,maybe a bit further down the line when they get everything worked out with what they adopt to replace Obamacare and how they deal with medicare. Its looking like cuts at this stage.
The other issue is whether Urologists will resist changing to a urine test alone .
Its possible anything new will have alot of complications getting accepted,not because its not a good test and cheaper. Systems are sometimes ridiculously stupid,especially with change--might be something as frustrating as a cutback on staff at the medicare or other offices or running with the outfit that provides enough sweeteners--or possibly just getting beaten down on the price--or none of the above including sailing straight through and being accepted after all these years.
Id think though that they would be holding fire on many things until they knew better what is actually going to happen with the whole system.--There are probably alot more important things to be dealt with than a urine test at this stage....but who knows....all im saying is be prepared for it not being business as usual.
The KP trial and clinical validation is a deal where KP has a user program to assess cxbladder for possible use in their not insignificant network.
On the successful conclusion of clinical validation they will eventually elect to either use the test or not once all the data is in. The savvy negotiations as you put it are in fact happening and have been all along with every User Program initiated.
The KP program turned out to be a much larger validation than the originally planned Triage as well, validating Detect and Resolve from each sample accounting for the extra time required.
Savvy negotiations? You betcha. Happening already and has been for some time
Skid I agree that this has been discussed before over and over again and I confer with most of your last post especially the last point, "be prepared for it not being business as usual". Once the paper work and trials have been completed "business will not be as it has been for Pacific Edge, it will be very different".
Frankly Skid, it will be great for PEB if it's NOT business as usual - BAU means continuing with expensive and invasive tests for bladder cancer.
I don't for one minute think the whole medical system is going to go on hold and that nobody in the USA will consider a proven, convenient, non-invasive test while Donald Trump decides what colour carpet he wants in the Oval office.
I guess you're looking at PEB's prospects as a glass half empty while I'm looking at one that's half-full. Just a matter of opinion really - and like a backside, we've all got one.
Meilleurs voeux
Pierre
I know why the yanks aren't falling over themselves (yet!) to get their hands on the CXBladder products' suite.
If DD & Co could somehow get the CXBladder specimen cup to look like a military weapon (and advertised as such) - PEB would not be able to keep up with the demand!!
(BTW, I used the term "military weapon" because I was too scared to use the "B" or "M" word on the internet). ;)
Must be very disappointing for some on here to see the SP creeping up this week and closing at 60cents. Would have to be those pesky underwriters looking out for themselves again I guess.